US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 13.210
  • -1.980-13.03%
Close Apr 25 16:00 ET
  • 13.990
  • +0.780+5.90%
Pre 08:34 ET
1.15BMarket Cap-5573P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.27%206.06M
39.24%59.52M
29.57%51.44M
34.14%49.25M
65.26%45.86M
101.96%146.91M
94.51%42.74M
106.33%39.7M
137.83%36.72M
72.50%27.75M
Selling and administrative expenses
23.25%75.54M
32.57%22.17M
3.46%18.28M
20.57%17.07M
41.44%18.03M
110.20%61.29M
55.04%16.72M
88.07%17.66M
156.27%14.16M
268.99%12.75M
-General and administrative expense
23.25%75.54M
32.57%22.17M
3.46%18.28M
20.57%17.07M
41.44%18.03M
110.20%61.29M
55.04%16.72M
88.07%17.66M
156.27%14.16M
268.99%12.75M
Research and development costs
52.45%130.52M
43.54%37.35M
50.50%33.16M
42.65%32.18M
85.48%27.83M
96.44%85.62M
132.55%26.02M
123.73%22.04M
127.56%22.56M
18.77%15M
Operating profit
-40.27%-206.06M
-39.24%-59.52M
-29.57%-51.44M
-34.14%-49.25M
-65.26%-45.86M
-101.96%-146.91M
-94.51%-42.74M
-106.33%-39.7M
-137.83%-36.72M
-72.50%-27.75M
Net non-operating interest income expense
Other net income (expense)
262.67%17.15M
90.05%5.01M
177.73%5.29M
1,694.18%3.39M
346,100.00%3.46M
43,081.82%4.73M
14,533.33%2.63M
27,100.00%1.9M
800.00%189K
112.50%1K
Gain on sale of security
262.14%17.19M
88.87%5.02M
179.21%5.29M
1,702.12%3.41M
173,200.00%3.47M
118,550.00%4.75M
--2.66M
--1.9M
--189K
--2K
Other non- operating income (expenses)
-122.22%-40K
30.77%-18K
-133.33%-3K
---15K
-300.00%-4K
-20.00%-18K
-285.71%-26K
28.57%9K
----
87.50%-1K
Income before tax
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-136.09%-36.53M
-72.33%-27.75M
Income tax
Net income
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-136.09%-36.53M
-72.33%-27.75M
Net income continuous Operations
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-136.09%-36.53M
-72.33%-27.75M
Minority interest income
0
0
Net income attributable to the parent company
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-101.26%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-155.78%-36.53M
-82.76%-27.75M
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
16.68%-142.18M
-82.83%-40.11M
-96.44%-37.8M
68.03%-36.53M
-82.76%-27.75M
Basic earnings per share
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
53.03%-2.17
-58.14%-0.56
-60.61%-0.53
88.10%-0.6
-90.77%-0.48
Diluted earnings per share
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
53.03%-2.17
-58.14%-0.56
-60.61%-0.53
88.10%-0.6
-90.77%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.27%206.06M39.24%59.52M29.57%51.44M34.14%49.25M65.26%45.86M101.96%146.91M94.51%42.74M106.33%39.7M137.83%36.72M72.50%27.75M
Selling and administrative expenses 23.25%75.54M32.57%22.17M3.46%18.28M20.57%17.07M41.44%18.03M110.20%61.29M55.04%16.72M88.07%17.66M156.27%14.16M268.99%12.75M
-General and administrative expense 23.25%75.54M32.57%22.17M3.46%18.28M20.57%17.07M41.44%18.03M110.20%61.29M55.04%16.72M88.07%17.66M156.27%14.16M268.99%12.75M
Research and development costs 52.45%130.52M43.54%37.35M50.50%33.16M42.65%32.18M85.48%27.83M96.44%85.62M132.55%26.02M123.73%22.04M127.56%22.56M18.77%15M
Operating profit -40.27%-206.06M-39.24%-59.52M-29.57%-51.44M-34.14%-49.25M-65.26%-45.86M-101.96%-146.91M-94.51%-42.74M-106.33%-39.7M-137.83%-36.72M-72.50%-27.75M
Net non-operating interest income expense
Other net income (expense) 262.67%17.15M90.05%5.01M177.73%5.29M1,694.18%3.39M346,100.00%3.46M43,081.82%4.73M14,533.33%2.63M27,100.00%1.9M800.00%189K112.50%1K
Gain on sale of security 262.14%17.19M88.87%5.02M179.21%5.29M1,702.12%3.41M173,200.00%3.47M118,550.00%4.75M--2.66M--1.9M--189K--2K
Other non- operating income (expenses) -122.22%-40K30.77%-18K-133.33%-3K---15K-300.00%-4K-20.00%-18K-285.71%-26K28.57%9K----87.50%-1K
Income before tax -32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M-96.44%-37.8M-136.09%-36.53M-72.33%-27.75M
Income tax
Net income -32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M-96.44%-37.8M-136.09%-36.53M-72.33%-27.75M
Net income continuous Operations -32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M-96.44%-37.8M-136.09%-36.53M-72.33%-27.75M
Minority interest income 00
Net income attributable to the parent company -32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-101.26%-142.18M-82.83%-40.11M-96.44%-37.8M-155.78%-36.53M-82.76%-27.75M
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders -32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M16.68%-142.18M-82.83%-40.11M-96.44%-37.8M68.03%-36.53M-82.76%-27.75M
Basic earnings per share -9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.5953.03%-2.17-58.14%-0.56-60.61%-0.5388.10%-0.6-90.77%-0.48
Diluted earnings per share -9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.5953.03%-2.17-58.14%-0.56-60.61%-0.5388.10%-0.6-90.77%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg